LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a target name.
REQUEST A FREE TRIAL
Pipeline
Deals
Financings
Articles
BioCentury
|
Apr 25, 2020
Translation in Brief
Molecular Partners’ trifunctional COVID-19 therapeutic; plus F-star, Inscopix and Ocean Biomedical
BioCentury's roundup of preclinical news
Read More
BioCentury
|
Jun 10, 2019
Company News
Tilos takeout sees Merck tapping TGFβ to solve checkpoint resistance
Read More
BioCentury
|
Mar 22, 2019
Company News
argenx gets first milestone payment from AbbVie for immuno-oncology therapy
Read More
BioCentury
|
Aug 31, 2018
Company News
AbbVie exercises option for argenx cancer candidate
Read More
BioCentury
|
Aug 22, 2018
Company News
AbbVie exercises option for argenx cancer candidate
Read More
BioCentury
|
Oct 31, 2017
Distillery Techniques
Biomarkers
Read More
BioCentury
|
Oct 24, 2017
Preclinical News
GWAS identify new risk loci in allergies and breast cancer
Read More
BioCentury
|
Jul 6, 2017
Emerging Company Profile
LAPping up TGF beta
How Tilos aims to enhance antitumor immunity with antibodies against TGF beta LAP
Read More
BioCentury
|
Apr 25, 2016
Company News
argenx, AbbVie deal
Read More
BioCentury
|
Apr 22, 2016
Company News
AbbVie gets option for argenx mAb
Read More
Items per page:
10
1 - 10 of 19